Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-177361
Filing Date
2026-04-24
Accepted
2026-04-24 16:25:04
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-24

Document Format Files

Seq Description Document Type Size
1 ARS apge_ars_2026.pdf ARS 2498023
  Complete submission text file 0001193125-26-177361.txt   3431701
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41740 | Film No.: 26894517
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)